83 related articles for article (PubMed ID: 15541821)
1. Magnetic resonance imaging and computed tomography in the diagnoses of brain metastases of lung cancer.
Suzuki K; Yamamoto M; Hasegawa Y; Ando M; Shima K; Sako C; Ito G; Shimokata K
Lung Cancer; 2004 Dec; 46(3):357-60. PubMed ID: 15541821
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
Katakami N; Inaba Y; Sugata S; Tsurusaki M; Itoh T; Machida T; Tanaka H; Nakayama T; Morikawa T; Breuer J; Aitoku Y
Invest Radiol; 2011 Jul; 46(7):411-8. PubMed ID: 21467949
[TBL] [Abstract][Full Text] [Related]
3. Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI).
Seute T; Leffers P; ten Velde GP; Twijnstra A
Cancer; 2008 Apr; 112(8):1827-34. PubMed ID: 18311784
[TBL] [Abstract][Full Text] [Related]
4. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
Cai L; Gao S; Li DC; Li YS; Chen QS; Xing XL
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892
[TBL] [Abstract][Full Text] [Related]
5. [Detectability of metastatic brain tumors using gadoteridol-enhanced MRI: usefulness of standard-dose T1-weighted spin-echo image with magnetization transfer and enhanced FLAIR].
Annoura K; Utsunomiya H; Arai S; Okazaki M
Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Mar; 60(3):77-82. PubMed ID: 10741113
[TBL] [Abstract][Full Text] [Related]
6. Brain metastasis of small cell lung carcinoma: comparison of Gd-DTPA enhanced magnetic resonance imaging and enhanced computerized tomography.
Nomoto Y; Miyamoto T; Yamaguchi Y
Jpn J Clin Oncol; 1994 Oct; 24(5):258-62. PubMed ID: 7967105
[TBL] [Abstract][Full Text] [Related]
7. Phase II clinical trial of gadoteridol injection, a low-osmolal magnetic resonance imaging contrast agent.
Carvlin MJ; De Simone DN; Meeks MJ
Invest Radiol; 1992 Aug; 27 Suppl 1():S16-21. PubMed ID: 1506148
[TBL] [Abstract][Full Text] [Related]
8. Imaging of brain metastases of bronchial carcinomas with 7 T MRI - initial results.
Mönninghoff C; Maderwald S; Theysohn JM; Schütt P; Gauler T; Kraff O; Ladd ME; Ladd SC; Wanke I
Rofo; 2010 Sep; 182(9):764-72. PubMed ID: 20544578
[TBL] [Abstract][Full Text] [Related]
9. Difference in enhancement between spin echo and 3-dimensional fast spoiled gradient recalled acquisition in steady state magnetic resonance imaging of brain metastasis at 3-T magnetic resonance imaging.
Furutani K; Harada M; Mawlan M; Nishitani H
J Comput Assist Tomogr; 2008; 32(2):313-9. PubMed ID: 18379324
[TBL] [Abstract][Full Text] [Related]
10. [Double-dose Gd-DTPA: detectability of intraparenchymal brain metastasis].
Tatsuno S; Hata Y; Tada S
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Oct; 56(12):855-9. PubMed ID: 8940816
[TBL] [Abstract][Full Text] [Related]
11. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
12. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX
Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
[TBL] [Abstract][Full Text] [Related]
13. [How can metastatic extension be assessed in the brain?].
Baleriaux D; Lemort M
Rev Mal Respir; 1992; 9 Suppl 4():R277-80. PubMed ID: 1336873
[TBL] [Abstract][Full Text] [Related]
14. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
[TBL] [Abstract][Full Text] [Related]
15. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis of cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intraindividual evaluation of a phase II high dose study].
Vogl TJ; Friebe CE; Balzer T; Mack MG; Steiner S; Schedel H; Pegios W; Lanksch W; Banzer D; Felix R
Radiologe; 1995 Aug; 35(8):508-16. PubMed ID: 7568795
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of contrast-enhanced computed tomography, computed tomography during arterioportography, and magnetic resonance imaging for staging colorectal liver metastases for liver resection.
Bhattacharjya S; Bhattacharjya T; Baber S; Tibballs JM; Watkinson AF; Davidson BR
Br J Surg; 2004 Oct; 91(10):1361-9. PubMed ID: 15376205
[TBL] [Abstract][Full Text] [Related]
18. [Comparative evaluation of computerized tomography/magnetic resonance (1.5 T) in the detection of brain metastasis].
Golfieri R; Cherryman GR; Olliff JF; Husband JE
Radiol Med; 1991; 82(1-2):27-34. PubMed ID: 1654578
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer and its operable brain metastasis: survival rate and staging problems.
Furák J; Troján I; Szöke T; Agócs L; Csekeö A; Kas J; Svastics E; Eller J; Tiszlavicz L
Ann Thorac Surg; 2005 Jan; 79(1):241-7; discussion 241-7. PubMed ID: 15620950
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
Budiharto T; Joniau S; Lerut E; Van den Bergh L; Mottaghy F; Deroose CM; Oyen R; Ameye F; Bogaerts K; Haustermans K; Van Poppel H
Eur Urol; 2011 Jul; 60(1):125-30. PubMed ID: 21292388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]